CXXC4 and severe congenital neutropenia: Hence, rather than being frequently involved in the leukemic progression of SCN, the CXXC4-ITD mutation should be taken as evidence that downregulation of TET2 and the associated upregulation of inflammatory signaling contribute to malignant transformation in conjunction with the CSF3R and RUNX1 mutations.